Mineralys Therapeutics (MLYS) Shares Issued (2022 - 2026)

Mineralys Therapeutics has disclosed Shares Issued across 5 years of filings, most recently posting $4.1 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $4.1 million, up 3196.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 103.61% YoY), and the FY2025 annual result was $243000.0, up 9.95% from the prior year.
• Shares Issued came in at $4.1 million for Q1 2026 at Mineralys Therapeutics, up from -$7.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $203.0 million in Q3 2023 to a low of -$202.8 million in Q4 2023.
• The 5-year median for Shares Issued is $83000.0 (2024), against an average of $280363.6.
• Across the five-year window, Shares Issued plunged 12349.11% in 2023 and jumped 3196.75% in 2026, its largest moves.
• Mineralys Therapeutics' Shares Issued stood at -$1.6 million in 2022, then slumped by 12349.11% to -$202.8 million in 2023, then jumped by 100.04% to $83000.0 in 2024, then sank by 9236.14% to -$7.6 million in 2025, then jumped by 153.47% to $4.1 million in 2026.
• The last three Shares Issued figures came in at $4.1 million (Q1 2026), -$7.6 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.